Physician profile
William E Burr
NPI 1710989918
$2,067.49
in general payments reported to CMS, 2019-2025
16 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,240 · 2020: $40.18 · 2021: $149 · 2022: $235 · 2023: $82.00 · 2024: $198 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,337.86 | 2019-2025 | Clareon, Hydrus Microstent |
| Horizon Therapeutics Plc | $133.82 | 2022-2023 | Tepezza |
| Rxsight INC | $119.92 | 2022-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $80.32 | 2022-2024 | Idose |
| Aerie Pharmaceuticals, INC. | $61.47 | 2019-2020 | |
| The Cameron-Ehlen Group, INC. | $51.14 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $48.45 | 2025 | Envista Envy Iol |
| Mallinckrodt Hospital Products INC. | $44.17 | 2025 | Acthar |
| Sight Sciences, INC. | $39.32 | 2020-2024 | Omni Surgical System |
| Abbvie INC. | $31.06 | 2024 | |
| Novartis Pharmaceuticals Corporation | $30.12 | 2019 | |
| Harrow Eye, LLC | $24.65 | 2023 | Iheezo |
| Alcon Research LLC | $16.91 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.25 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $16.02 | 2024 | Lumera 700 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $16.01 | 2025 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Burr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.